149
Participants
Start Date
May 4, 2017
Primary Completion Date
July 27, 2020
Study Completion Date
August 2, 2022
Abatacept subcutaneous
Specified dose of Abatacept subcutaneous on specified days
Placebo
Placebo of Abatacept subcutaneous
Local Institution - 0051, Camperdown
Local Institution - 0053, St Leonards
Local Institution - 0035, Auchenflower
Local Institution - 0036, Murdoch
Local Institution - 0097, New York
Local Institution - 0027, Berlin
Local Institution - 0046, Mexico City
Local Institution - 0014, Pittsburgh
Local Institution - 0037, Stockholm
Local Institution - 0055, Bethlehem
Local Institution - 0057, Washington D.C.
Johns Hopkins University -Johns Hopkins Bayview Medical Center, Baltimore
Local Institution - 0040, Lund
Local Institution - 0028, Hamburg
Local Institution - 0023, Pavia
Local Institution - 0010, Wilmington
Local Institution - 0005, Orangeburg
Local Institution - 0100, Brest
Local Institution - 0013, Miami
Local Institution - 0018, Fort Lauderdale
Local Institution - 0020, Padua
Local Institution - 0017, Jackson
Local Institution - 0056, Columbus
Local Institution - 0031, Ferrara
Local Institution - 0094, Middleburg Heights
Local Institution - 0048, Guadalajara
Local Institution - 0089, Ann Arbor
Local Institution - 0024, Florence
Local Institution - 0002, Eagan
Local Institution - 0025, Pisa
Local Institution - 0043, Lille
Local Institution - 0045, Clermont-Ferrand
Local Institution - 0006, Kansas City
Local Institution - 0044, Strasbourg
Local Institution - 0041, Örebro
Local Institution - 0038, Västerås
Local Institution - 0059, Norman
Local Institution - 0042, Paris
Local Institution - 0016, Houston
Local Institution - 0047, San Luis Potosí City
Local Institution - 0052, San Luis Potosí City
Local Institution - 0096, Austin
Local Institution - 0030, München
Local Institution - 0015, Phoenix
Local Institution - 0075, Beverly Hills
Local Institution - 0012, Orange
Local Institution - 0095, Seattle
Local Institution - 0079, Bunkyo-ku
Local Institution - 0092, Shinjuku-ku
Local Institution - 0093, Shinjuku-Ku
Local Institution - 0083, Kawasaki-shi
Local Institution - 0082, Tsukuba
Local Institution - 0077, Iruma-gun
Local Institution - 0088, Nagasaki
Local Institution - 0084, Kumamoto
Local Institution - 0069, Juiz de Fora
Local Institution - 0073, Salvador
Local Institution - 0058, Boston
Local Institution - 0011, Omaha
Local Institution - 0004, Lebanon
Local Institution - 0070, Vitória
Local Institution - 0072, Porto Alegre
Local Institution - 0074, Bairro Jardim
Local Institution - 0067, Rio Grande
Local Institution - 0071, São Paulo
Local Institution - 0029, Prague
Local Institution - 0054, Halle
Local Institution - 0091, Kitakyushu
Local Institution - 0090, Sapporo
Local Institution - 0078, Sapporo
Local Institution, Sasebo
Local Institution - 0086, Bunkyo-ku
Local Institution - 0081, Chuo-ku
Local Institution - 0087, Ube-shi
Local Institution - 0076, Miyagi
Local Institution - 0049, Mexico City
Local Institution - 0066, Seoul
Local Institution - 0065, Seoul
Local Institution - 0064, Seoul
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY